| IMMUTEP Immutep Limited
98349654 09 Jan 2024 | on 31 Dec 2024
| Pharmaceutical preparations for the treatment of cancer, auto-immune d... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of cancer, auto-immune diseases and infectious diseases; pharmaceutical preparations containing antibodies for the treatment of cancer, auto-immune diseases and infectious diseases; pharmaceutical preparations containing recombinant proteins for the treatment of cancer, auto-immune diseases and infectious diseases | | | IMMUTEP IMMUTEP LIMITED
79227393 14 Dec 2017 | on 18 Dec 2024 | Pharmaceutical preparations for the treatment of cancer, [ auto-immune... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of cancer, [ auto-immune diseases and infectious diseases; pharmaceutical preparations containing antibodies for the treatment of cancer, auto-immune diseases and infectious diseases; ] pharmaceutical preparations containing recombinant proteins for the treatment of cancer [ , auto-immune diseases and infectious diseases ] | | | PRIMA BIOMED Immutep Limited
79191113 06 May 2016 | on 01 Mar 2024 | Pharmaceutical and veterinary preparations for the treatment of cancer... Class 001 Class 001 Chemical Products In the Statement, line 12, after DISEASES, "; none of the aforementioned being for use by lactating and pregnant women" should be inserted. Class 005 Class 005 Pharmaceutical Products Pharmaceutical and veterinary preparations for the treatment of cancer and autoimmune diseases [ ; ] *, * reactants and reagents for medical diagnostic purposes; diagnostic preparations and reagents for medical purposes; antibodies and recombinant proteins for use in medical applications, namely, adjuvants for the treatment of cancer and autoimmune diseases * ; none of the aforementioned being for use by lactating and pregnant women * | | 
